Paydirt
MP
Insider

Mark L Pacala

Director · Starling Oncology

Mark L Pacala (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Starling Oncology Inc (TOI). The largest single filing was $187K of TOI (46,630 sh × $4.00, as filed), executed Nov 18 2025. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Nov 18 2025
Filed Nov 20 2025

Median ADV $10.2M across their filed names

Open performance→
Volume by month
$187K$93K$0Dec 2024Jun 2025Dec 2025Jun 2026Nov 2025 · sells $187K
Buys $0 Sells $187K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
TOI Starling Oncology Inc TOI · 0 buys · 1 sell 1 filing
Recent filings
TOISALE Starling Oncology Inc View filing → $187K
46,630 sh × $4.00
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET